Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359679 · ClinicalTrials.gov registry record · NA
Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 3,300
- Enrollment target
NCT05359679 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 3,300 participants.
The verdict
NCT05359679, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,300 participants
- Enrollment target
Study Summary
The primary objective is to assess the effectiveness of training a clinician to be a 'value champion' within clinical settings to decrease the use of three classes of potentially inappropriate prescription medications (PIMs) among people living with dementia (PLWD). Secondary objectives include determining if the intervention is associated with a reduction in emergency department (ED) visits or hospitalizations due to a fall, and examining five implementation outcomes: appropriateness, feasibility, fidelity, penetration, and equity. This study is a pragmatic cluster-randomized trial to test the effectiveness of a primary care clinician value champion for de-implementing PIMs among patients 65 years of age and older with a diagnosis of dementia. Medicare Part D pharmacy claims data will be analyzed at the end of the 12-month intervention for the primary outcome, the medication possession rates (MPR) for three groups of potentially inappropriate medications: antipsychotic medications, benzodiazepines, and hypoglycemic medications (sulfonylureas and insulin). In a similar fashion, a hospital admission, or an emergency department visit for a fall will be assessed at the end of the intervention using Medicare claims data. Finally, the five implementation outcomes will be evaluated at the end of the intervention from notes entered by the value champions in project workbooks. Primary care clinics within each of the two participating ACOs will be randomized to either the intervention or control arms of the study. Prior to random assignment, the investigators will stratify practices based on high versus low historic prescribing rates. A primary care clinician from each clinic selected for the trial in the intervention arm (n=30 across the two ACOs) will be recruited as a clinician value champion for each intervention clinic. The clinician value champion will participate in twice monthly value champion web-based training sessions for six months and then launch a 12-month in
Interventions
- OTHER No Intervention
- BEHAVIORAL Value Champion Training Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,300 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05359679
The ClinicalTrials.gov registry entry for NCT05359679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Intervention is the first listed.
NCT05359679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05359679 about?
NCT05359679 is a clinical study titled "Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?". The primary objective is to assess the effectiveness of training a clinician to be a 'value champion' within clinical settings to decrease the use of three classes of potentially inappropriate prescription medications (PIMs) among people living with dementia (PLWD). Secondary objectives include dete...
What is the current status of trial NCT05359679?
This trial is currently completed. It is a NA study. The enrollment target is 3,300 participants. The study started on 2023-08-30. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT05359679?
The interventions under investigation include: No Intervention (OTHER), Value Champion Training Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05359679?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.